Ulrich Costabel

9PUBLICATIONS
32CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classifiedInfant and child healthGene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 30, 2023
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies.

Jürgen Behr, Steven D Nathan, Ulrich Costabel

|Jan 05, 2023
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.

Spyros A Papiris, Ilaria Campo, Francesca Mariani

|Nov 03, 2022
GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial.

Irina R Strambu, Christian A Seemayer, Liesbeth M-C A Fagard

|Aug 23, 2022
Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy.

Sebastian Majewski, Maria Królikowska, Ulrich Costabel

|Oct 03, 2020
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis.

Toby M Maher, Ulrich Costabel, Marilyn K Glassberg

|Aug 21, 2020
Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial.

Jürgen Hetzel, Athol U Wells, Ulrich Costabel

Pageof 2

Frequent Collaborators

2 joint publications

Francesco Bonella

2 joint publications

Marilyn K Glassberg

2 joint publications

Elisabeth Bendstrup

1 joint publications

Shinichiro Ohshimo